Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Medicale (MCLE) Profit After Tax (2020 - 2025)

Medicale's Profit After Tax history spans 6 years, with the latest figure at -$10670.0 for Q3 2025.

  • For Q3 2025, Profit After Tax rose 36.79% year-over-year to -$10670.0; the TTM value through Sep 2025 reached -$41153.0, up 29.31%, while the annual FY2025 figure was -$41153.0, 29.31% up from the prior year.
  • Profit After Tax reached -$10670.0 in Q3 2025 per MCLE's latest filing, down from -$5528.0 in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$5528.0 in Q2 2025 to a low of -$19307.0 in Q4 2023.
  • Average Profit After Tax over 5 years is -$10650.6, with a median of -$8537.0 recorded in 2023.
  • Peak YoY movement for Profit After Tax: skyrocketed 55.82% in 2022, then tumbled 133.77% in 2023.
  • A 5-year view of Profit After Tax shows it stood at -$18696.0 in 2021, then surged by 55.82% to -$8259.0 in 2022, then crashed by 133.77% to -$19307.0 in 2023, then increased by 13.61% to -$16680.0 in 2024, then soared by 36.03% to -$10670.0 in 2025.
  • Per Business Quant, the three most recent readings for MCLE's Profit After Tax are -$10670.0 (Q3 2025), -$5528.0 (Q2 2025), and -$8275.0 (Q1 2025).